Title:
リキシセナチドを用いた小児２型真性糖尿病患者の治療
Document Type and Number:
Japanese Patent JP7274258
Kind Code:
B2
Abstract:
The present invention refers to lixisenatide for use in pediatrics.
Inventors:
Carlin Bergmann
Agnes Inserin-Merry
Christel Yang
Agnes Inserin-Merry
Christel Yang
Application Number:
JP2017537500A
Publication Date:
May 16, 2023
Filing Date:
January 15, 2016
Export Citation:
Assignee:
Sanofi-Aventis Deutschland Gesellschaft Mitt Beschlenktel Haftung
International Classes:
A61K38/16; A61K31/155; A61P3/10
Domestic Patent References:
| JP2014514356A | ||||
| JP2012516309A |
Other References:
U.S. National Institutes of Health, ” Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes”, last update:2014.05.23, [retrieved on 2020.07.10], retrieved from the internet:
Attorney, Agent or Firm:
Junji Yuda
Noriyuki Takebayashi
Noriyuki Takebayashi
Previous Patent: Polymorph of 9,9-bis[4-(2-hydroxyethoxy)-3-phenylphenyl]fluorene and method for producing same
Next Patent: REMOTE CONTROL SYSTEM
Next Patent: REMOTE CONTROL SYSTEM